FEATURED FUNDS
DSP Small Cap Direct Plan-Growth
5Y Return
15.85 %
Invest Now
FEATURED FUNDS
DSP Tax Saver Direct Plan-Growth
5Y Return
17.64 %
Invest Now
FEATURED FUNDS
Mirae Asset Equity Savings Fund Direct - Growth
2Y Return
17.74 %
Invest Now
FEATURED FUNDS
Mirae Asset Hybrid Equity Fund Direct-Growth
5Y Return
16.44 %
Invest Now
FEATURED FUNDS
DSP Equity Opportunities Direct Plan-Growth
5Y Return
16.74 %
Invest Now
Healthcare
Ayushman Bharat has transformed healthcare system in country: Health Minister Mandaviya
Exhorting the medical community to serve everyone with dedication, Mandaviya said the government can only initiate action, passion can only come from service providers.
India to export 8 million Covid-19 jabs in October
Prime Minister Narendra Modi promised to resume exports at a meeting of leaders from the so-called Quad in Washington as India, Japan, Australia, and the US try to counter growing Chinese influence across the Asia-Pacific region.
Adults over 40 with diabetes, COVID-19 more likely to be hospitalised than children: Study
People with diabetes and COVID-19 who were 40 and older were more likely to experience adverse outcomes such as death, diabetic ketoacidosis or severe hypoglycemia.
Scientists develop insulin that can be kept without refrigeration
This is being hailed as a big breakthrough in scientific circles, as portability has always been a concern for insulin-dependent people.
ICMR removes Ivermectin and Hydroxycholoquine (HCQ) from Covid-19 treatment guidelines
Experts at India's health research body did not find enough evidence for Ivermectin and HCQ of a potential therapeutic effect against Covid-19, Samiran Panda head of epidemiology and infectious diseases at ICMR told ET.
Mansukh Mandaviya releases guidelines on treatment of long-term health conditions post Covid
According to a Health Ministry statement, the minister said these "post-COVID Sequelae modules" will help in building the capacity of doctors, nurses, paramedics and community health workers across the country.
No evidence of any new variant of SARS-CoV2 in country: INSACOG
Last week, the INSACOG said India has so far not seen Mu and C.1.2, the two new variants of SARS'CoV2, and the Delta variant and its sub-lineages continue to be the main variants in the country.
Vaccine at home for differently-abled, people with restricted mobility: Govt
Thirty-three districts in the country are now reporting over 10 per cent weekly positivity rate, while 23 are recording between 5-10 per cent.
20% beds in govt hospitals will be reserved for children to fight COVID third wave: Karnataka Health Minister
Karnataka Health Minister said about 285 paediatricians, 1,250 medical officers, 1,202 nurses, along with 85 paediatricians recruited on July 6-7, have been given special training regarding providing treatment for third wave of COVID.
Long COVID: Double vaccination halves risk of developing long-lasting symptoms
Double-vaccinated people are 31% less likely to experience acute COVID-19 symptoms and 73% less likely to be hospitalised – a result that's borne out in the relatively low hospitalisation and death rates we're seeing now even as tens of thousands of people are still testing positive every day in the UK.
Selco & Crypto Relief to lift health units with solar solution in 10 districts
Selco will provide solar energy solutions across 1278 healthcare facilities in 10 districts in Karnataka, Manipur, Meghalaya, Nagaland, and Odisha, and make their medical equipment energy, Crypto Relief and Selco said in a press release.
Serum Institute to supply nearly 22 crore doses of Covishield vaccine to Centre in October
The Pune-based pharmaceutical company has enhanced the manufacturing capacity of Covishield to more than 20 crore doses per month.
QubeHealth & Nova Benefits to provide full-stack health and wellness benefits to Indian companies
The company wll provide pre-approved healthcare financing, health insurance, and a healthcare marketplace for Indian corporates and their employees.
AIIMS Delhi prepares hi-tech Smart Lab to conduct 2 lakh tests in a day
All India Institute of Medical Sciences (AIIMS), Delhi has prepared a 'smart lab' which has the capacity to conduct more than two lakh general tests in a single day. This hi-tech lab was started last year in July and also inaugurated by former Union Health Minister Dr Harsh Vardhan. AIIMS Hi-tech lab is also providing some free-of-cost tests such as the D-Dimer test that costs around Rs 1,000 in private labs.
Covaxin for kids: Bharat Biotech completes phase 2/3 trials of vaccine, to submit data to DCGI next week
Bharat Biotech has completed the Phase 2/3 trials of COVID-19 vaccine, Covaxin for use in children under 18 years of age and is expected to submit the data by next week to the DCGI, Chairman and Managing Director of Bharat Biotech International Ltd, Krishna Ella said on Tuesday here. Speaking to reporters, he said Covaxin production would touch 55 million doses in October as against 35 million in September.
Antibodies from earlier Covid strain may not help fight variants
The finding has implications for the ability of new variants to reinfect people who contracted earlier versions of the virus.
Load More...
BACK TO TOP